5-hydroxytryptophan / magnesium oxide / melatonin / tryptophan / vitamin B6 Oral Capsule [Somnicin]
- RxCUI
- 1293417
- RxNorm name
- 5-hydroxytryptophan / magnesium oxide / melatonin / tryptophan / vitamin B6 Oral Capsule [Somnicin]
- Term type
- SBDF
- Status
- Active
- Updated
- 2026-07-30 22:48:42
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 062012
- Active start
- 062012
- Multiple ingredient
- YES
- Branded
- YES
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Capsule | 316965 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| tryptophan | 10898 |
| vitamin B6 | 42954 |
| magnesium oxide | 6582 |
| melatonin | 6711 |
| 5-hydroxytryptophan | 94 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | 5-hydroxytryptophan / magnesium oxide / melatonin / tryptophan / vitamin B6 Oral Capsule [Somnicin] | NAMES |
| RxNorm Name | 5-hydroxytryptophan / magnesium oxide / melatonin / tryptophan / vitamin B6 Oral Capsule [Somnicin] | NAMES |
| TTY | SBDF | ATTRIBUTES |
| RxCUI | 1293417 | CODES |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A12CC | Magnesium | ATC1-4 | magnesium oxide | |
| ATC | A02AA | Magnesium compounds | ATC1-4 | magnesium oxide | |
| ATC | N05CH | Melatonin receptor agonists | ATC1-4 | melatonin | |
| ATC | A06AD | Osmotically acting laxatives | ATC1-4 | magnesium oxide | |
| ATC | N06AX | Other antidepressants | ATC1-4 | 5-hydroxytryptophan | |
| ATC | N06AX | Other antidepressants | ATC1-4 | tryptophan | |
| MEDRT | D006916 | 5-Hydroxytryptophan | CHEM | has_ingredient | 5-hydroxytryptophan |
| MEDRT | D008277 | Magnesium Oxide | CHEM | has_ingredient | magnesium oxide |
| MEDRT | D008550 | Melatonin | CHEM | has_ingredient | melatonin |
| MEDRT | D014364 | Tryptophan | CHEM | has_ingredient | tryptophan |
| MEDRT | D025101 | Vitamin B 6 | CHEM | has_ingredient | vitamin B6 |
| MEDRT | D000224 | Addison Disease | DISEASE | ci_with | magnesium oxide |
| MEDRT | D001064 | Appendicitis | DISEASE | ci_with | magnesium oxide |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | ci_with | magnesium oxide |
| MEDRT | D003863 | Depression | DISEASE | may_treat | tryptophan |
| MEDRT | D003967 | Diarrhea | DISEASE | induces | magnesium oxide |
| MEDRT | D004238 | Diverticulitis | DISEASE | ci_with | magnesium oxide |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | magnesium oxide |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | vitamin B6 |
| MEDRT | D004415 | Dyspepsia | DISEASE | may_treat | magnesium oxide |
| MEDRT | D006327 | Heart Block | DISEASE | ci_with | magnesium oxide |
| MEDRT | D006505 | Hepatitis | DISEASE | ci_with | magnesium oxide |
| MEDRT | D020179 | Jet Lag Syndrome | DISEASE | may_treat | melatonin |
| MEDRT | D020179 | Jet Lag Syndrome | DISEASE | may_prevent | melatonin |
| MEDRT | D008275 | Magnesium Deficiency | DISEASE | may_prevent | magnesium oxide |
| MEDRT | D008275 | Magnesium Deficiency | DISEASE | may_treat | magnesium oxide |
| MEDRT | D010146 | Pain | DISEASE | may_treat | tryptophan |
| MEDRT | D051437 | Renal Insufficiency | DISEASE | ci_with | magnesium oxide |
| MEDRT | D016574 | Seasonal Affective Disorder | DISEASE | may_treat | melatonin |
| MEDRT | D007319 | Sleep Initiation and Maintenance Disorders | DISEASE | may_treat | tryptophan |
| MEDRT | D026681 | Vitamin B 6 Deficiency | DISEASE | may_treat | vitamin B6 |
| MEDRT | D026681 | Vitamin B 6 Deficiency | DISEASE | may_prevent | vitamin B6 |
| MEDRT | N0000000226 | Acid-Base Activity | MOA | has_moa | magnesium oxide |
| MEDRT | N0000000220 | Electrolyte Activity | MOA | has_moa | magnesium oxide |
| MEDRT | N0000000163 | Enzyme Interactions | MOA | has_moa | vitamin B6 |
| MEDRT | N0000000163 | Enzyme Interactions | MOA | has_moa | magnesium oxide |
| MEDRT | N0000000149 | Hormone Receptor Agonists | MOA | has_moa | melatonin |
| MEDRT | N0000010288 | Osmotic Activity | MOA | has_moa | magnesium oxide |
| MEDRT | N0000008295 | Antacid | PE | has_pe | magnesium oxide |
| MEDRT | N0000008337 | Cellular Activity Alteration | PE | has_pe | magnesium oxide |
| MEDRT | N0000008337 | Cellular Activity Alteration | PE | has_pe | vitamin B6 |
| MEDRT | N0000009397 | Increased Melatonin Activity | PE | has_pe | melatonin |
| MEDRT | N0000009587 | Increased Serotonin Production | PE | has_pe | tryptophan |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | TTY | SBDF |
| CODES | RxCUI | 1293417 |
| NAMES | RXNAV_STR | 5-hydroxytryptophan / magnesium oxide / melatonin / tryptophan / vitamin B6 Oral Capsule [Somnicin] |
| NAMES | RxNorm Name | 5-hydroxytryptophan / magnesium oxide / melatonin / tryptophan / vitamin B6 Oral Capsule [Somnicin] |